L Lafleur

1.3k total citations
40 papers, 999 citations indexed

About

L Lafleur is a scholar working on Genetics, Immunology and Pharmacology. According to data from OpenAlex, L Lafleur has authored 40 papers receiving a total of 999 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 13 papers in Immunology and 10 papers in Pharmacology. Recurrent topics in L Lafleur's work include Yersinia bacterium, plague, ectoparasites research (11 papers), Pharmacological Effects of Natural Compounds (10 papers) and T-cell and B-cell Immunology (6 papers). L Lafleur is often cited by papers focused on Yersinia bacterium, plague, ectoparasites research (11 papers), Pharmacological Effects of Natural Compounds (10 papers) and T-cell and B-cell Immunology (6 papers). L Lafleur collaborates with scholars based in Canada, France and Sweden. L Lafleur's co-authors include S Toma, Melvin I. Marks, C. H. Pai, O. Hammerberg, L Chicoine, Jan Andersson, Fritz Melchers, Gilles Delage, François Proulx and Jean P. Turgeon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

L Lafleur

35 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Lafleur Canada 19 381 260 248 201 195 40 999
William Chamberlin United States 15 169 0.4× 114 0.4× 250 1.0× 93 0.5× 331 1.7× 28 1.0k
A B Onderdonk United States 19 259 0.7× 35 0.1× 367 1.5× 179 0.9× 385 2.0× 26 1.3k
Emanuel Suter United States 21 94 0.2× 43 0.2× 276 1.1× 545 2.7× 240 1.2× 47 1.3k
Alex C. Sonnenwirth United States 16 119 0.3× 74 0.3× 125 0.5× 38 0.2× 97 0.5× 32 576
M T van den Barselaar Netherlands 20 83 0.2× 32 0.1× 245 1.0× 642 3.2× 325 1.7× 35 1.4k
Anca Georgescu Romania 15 221 0.6× 63 0.2× 63 0.3× 130 0.6× 299 1.5× 51 877
Vijitr Boonpucknavig Thailand 18 119 0.3× 66 0.3× 164 0.7× 108 0.5× 76 0.4× 42 861
M. T. Labro France 21 112 0.3× 62 0.2× 205 0.8× 386 1.9× 200 1.0× 59 1.3k
C. L. Oakley United Kingdom 14 53 0.1× 41 0.2× 321 1.3× 134 0.7× 208 1.1× 37 917
Patricia A. Fontán Argentina 14 83 0.2× 98 0.4× 503 2.0× 193 1.0× 484 2.5× 26 1.3k

Countries citing papers authored by L Lafleur

Since Specialization
Citations

This map shows the geographic impact of L Lafleur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Lafleur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Lafleur more than expected).

Fields of papers citing papers by L Lafleur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Lafleur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Lafleur. The network helps show where L Lafleur may publish in the future.

Co-authorship network of co-authors of L Lafleur

This figure shows the co-authorship network connecting the top 25 collaborators of L Lafleur. A scholar is included among the top collaborators of L Lafleur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Lafleur. L Lafleur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fouillen, Aurélien, Hélène Orcel, L Lafleur, et al.. (2025). Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin. Nature Communications. 16(1). 3899–3899.
2.
Fayon, Michaël, Mauro R. Tucci, J. Lacroix, et al.. (1997). Nosocomial Pneumonia and Tracheitis in a Pediatric Intensive Care Unit: A Prospective Study. American Journal of Respiratory and Critical Care Medicine. 155(1). 162–169. 66 indexed citations
3.
Proulx, François, Jean P. Turgeon, Gilles Delage, et al.. (1995). Immune Response to Verotoxin 1 and 2 in Children with Escherichia Coli O157:H7 Hemorrhagic Colitis and Classic Hemolytic Uremic Syndrome. Canadian Journal of Infectious Diseases and Medical Microbiology. 6(3). 136–140. 1 indexed citations
4.
Lemay, Jacinthe, Marie Lambert, Grant A. Mitchell, et al.. (1992). Hyperammonemia-hyperornithinemia-homocitrullinuria syndrome: Neurologic, ophthalmologic, and neuropsychologic examination of six patients. The Journal of Pediatrics. 121(5). 725–730. 25 indexed citations
5.
Proulx, François, Jean P. Turgeon, Gilles Delage, L Lafleur, & L Chicoine. (1992). Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis. The Journal of Pediatrics. 121(2). 299–303. 116 indexed citations
6.
Ducharme, Francine M., Marie Gauthier, Jacques Lacroix, & L Lafleur. (1988). Incidence of infection related to arterial catheterization in children. Critical Care Medicine. 16(3). 272–276. 37 indexed citations
7.
Różalski, M., L Lafleur, & A. Ruiz‐Carrillo. (1985). Monoclonal antibodies against histone H5. Epitope mapping and binding to chromatin.. Journal of Biological Chemistry. 260(26). 14379–14386. 23 indexed citations
8.
Morin, Odette, et al.. (1984). Heterogeneity of endothelial cells of adult rat liver as resolved by sedimentation velocity and flow cytometry. Journal of Cellular Physiology. 119(3). 327–334. 34 indexed citations
9.
Marks, Melvin I., et al.. (1980). Yersinia enterocolitica gastroenteritis: A prospective study of clinical, bacteriologic, and epidemiologic features. The Journal of Pediatrics. 96(1). 26–31. 133 indexed citations
10.
Toma, S, et al.. (1979). Canadian experience with Yersinia enterocolitica (1966--1977).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 5. 144–9. 22 indexed citations
11.
Lafleur, L, et al.. (1979). Yersinia enterocolitica : biology, epidemiology, and pathology. S. Karger eBooks. 5 indexed citations
12.
Luzzati, Alma L. & L Lafleur. (1976). Suppressor cells in rabbit peripheral blood. European Journal of Immunology. 6(2). 125–129. 21 indexed citations
13.
Lafleur, L & Graham F. Mitchell. (1975). Differences in the immunological activities of antibody‐secreting cell precursors in mouse spleen selected on the basis of antigen‐binding capacity. European Journal of Immunology. 5(9). 648–652. 2 indexed citations
14.
Mitchell, Graham F., et al.. (1974). Evidence for Readily Induced Tolerance to Heterologous Erythrocytes in Nude Mice. Scandinavian Journal of Immunology. 3(1). 39–49. 32 indexed citations
15.
Laverdière, Michél, et al.. (1974). Yersiniosis in children.. PubMed. 110(3). 281–4. 44 indexed citations
16.
Lafleur, L, et al.. (1974). Survey on the Incidence of Yersinia enterocolitica Infection in Canada. Applied Microbiology. 28(3). 469–473. 37 indexed citations
17.
Lafleur, L, R. G. Miller, & Robert A. Phillips. (1973). RESTRICTION OF SPECIFICITY IN THE PRECURSORS OF BONE MARROW-ASSOCIATED LYMPHOCYTES. The Journal of Experimental Medicine. 137(4). 954–966. 43 indexed citations
18.
Lafleur, L, et al.. (1972). Differentiation of lymphocytes: characterization of early precursors of B lymphocytes.. PubMed. 5(2). 50–63. 10 indexed citations
19.
Lafleur, L, B Martineau, & L Chicoine. (1972). Yersinia enterocolitica: aspects biologiques, épidémiologiques et cliniques de 67 cas observés à l'Hôpital Sainte-Justine (Montréal-Canada.. 101(11). 5 indexed citations
20.
LaPointe, Nancy M. Allen, Richard M. Raymond, & L Lafleur. (1967). [Study of infectious agents of the mycoplasma type in infantile leukemia].. PubMed. 96(11). 1345–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Chamberlin Breakdown of academic impact, for papers by A B Onderdonk Breakdown of academic impact, for papers by Emanuel Suter Breakdown of academic impact, for papers by Alex C. Sonnenwirth Breakdown of academic impact, for papers by M T van den Barselaar Breakdown of academic impact, for papers by Anca Georgescu Breakdown of academic impact, for papers by Vijitr Boonpucknavig Breakdown of academic impact, for papers by M. T. Labro Breakdown of academic impact, for papers by C. L. Oakley Breakdown of academic impact, for papers by Patricia A. Fontán
Rankless by CCL
2026